At Hisun USA, our goal is to create a broad portfolio of generics through leveraging the diverse and expansive capabilities of our parent company while actively seeking to acquire products, technologies or companies with strategic value in the US market. Hisun holds 21 pending ANDAs with many more under development. We have been marketing ANDA product in US market for over one year and are planning to launch more ANDA products in the coming months. With a growing pipeline of oral solid dosage and injectable products, we are committed to develop and supply products through our extensive resources and experience:
- Focus on market and technologically differentiated products
- Vertically integrated with a well-established API business
- Proven biopharmaceutical & biosimilar development track record
For more information, please contact:
John Kline
Vice President, National Accounts
Office: 916-705-2747
Email: john.kline@hisunusa.com
Martin Wingerter
Vice President, National Accounts
Office: 214-676-3852
Email: martin.wingerter@hisunusa.com
Hisun Pharmaceuticals USA, Inc.
200 Crossing Blvd, 2nd Floor
Bridgewater, NJ 08807
For Returns: returns@hisunusa.com
For Customer Service: customerservice@hisunusa.com
For ROW market:
Hisun USA is one of the wholly owned subsidiaries of Zhejiang Hisun Pharmaceutical Co., Ltd. (Hisun Pharm).
Founded in 1956, Hisun Pharm is now one of leading pharmaceutical manufacturers in China, with drug products inspected/approved by US FDA and Health Canada. Broad portfolio of FDFs including antineoplastics, immunomodulating agents, antiinfectives, cardiovasculars, etc.
For more information, please contact:
Peggy Albanese
Vice President Corporate Development
Hisun Pharmaceuticals USA, Inc.
200 Crossing Blvd, 2nd Floor
Bridgewater, NJ 08807
Office: 609-454-0237
Email: Peggy.Albanese@hisunusa.com
Phoebe Zhang
Head of Sales, Overseas FDF
Office: 0086-21-2426-0206
Cell Ph#: 0086-139-2170-6326
E-mail: lijun.zhang@hisunpharm.com
Robin Yang
Reginal Manager (Middle East Asia), Overseas FDF
Cell Ph#: 0086-181-2143-2128
E-mail: bo.yang01@hisunpharm.com
To report SUSPECTED ADVERSE REACTIONS and product quality related issues, contact Hisun Pharmaceuticals USA, Inc. at 1-855-554-4786